Andrea Poli

COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain

Massimiliano Secchi, Elena Bazzigaluppi, Cristina Brigatti et al. · Journal of Clinical Investigation · 2020 · 106 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

Antonella Castagna, Camilla Muccini, Laura Galli et al. · Journal of Antimicrobial Chemotherapy · 2019 · 41 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +15

In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients

Francesco Saladini, Alessia Giannini, Federica Giammarino et al. · Journal of Antimicrobial Chemotherapy · 2020 · 16 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

Nicola Gianotti, Andrea Poli, Laura Galli et al. · PLoS ONE · 2017 · 11 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

Nicola Gianotti, Laura Galli, Nadia Galizzi et al. · International Journal of Antimicrobial Agents · 2018 · 11 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +10